Skip to main content
NIH funding notice RFA-DA-23-014

Avenir Award Program for Chemistry and Pharmacology of Substance Use Disorders (DP1- Clinical Trial Not Allowed)

Closed on August 11, 2022.

Posted
March 21, 2022
Close date
August 11, 2022
Activity codes
Not stated on the notice page
Institutes taking part
Not stated on the notice page

Read the notice on Grants.gov · NIH Guide page

The notices it replaced

Its page was not saved, so the notices it replaced are not known.

Who won it before

5 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $2,560,767 in first-year total cost, median $484,500.

Most frequent study sections

  1. Special Emphasis Panel[ZDA1 MXS-W (J5)]5

Most frequent institutions

  1. HIGH POINT UNIVERSITY1
  2. MASSACHUSETTS GENERAL HOSPITAL1
  3. RESEARCH TRIANGLE INSTITUTE1
  4. UNIVERSITY OF CALIFORNIA, SAN FRANCISCO1
  5. VANDERBILT UNIVERSITY1
Competing awards under RFA-DA-23-014 and the notices it replaced
FYProjectPIsInstitutionFirst-year costStudy section
2023Mitochondrial signaling dynamics in cocaine use disorder1DP1DA058362-01ABRAHAM, ANTONY DANIELRESEARCH TRIANGLE INSTITUTE, NC$652,767ZDA1
2023The neuropharmacology of brain activation during stages of drug abuse1DP1DA058360-01SANDER, CHRISTIN Y.MASSACHUSETTS GENERAL HOSPITAL, MA$501,000ZDA1
2023New Technologies for Accelerating the Discovery and Characterization of Neuroactives that Address Substance Use Disorders1DP1DA058350-01MCCARROLL, MATTHEW NUNIVERSITY OF CALIFORNIA, SAN FRANCISCO, CA$484,500ZDA1
2023Developing a computational platform for induced-fit and chemogenetic drug design1DP1DA058349-01BROWN, BENJAMIN PATRICKVANDERBILT UNIVERSITY, TN$475,500ZDA1
2023Development of High-Affinity and Selective Ligands as a Pharmacological Tool for the Dopamine D4 Receptor (D4R) Subtype Variants1DP1DA058385-01BOATENG, COMFORT AHENKANHIGH POINT UNIVERSITY, NC$447,000ZDA1

Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.

ScienceDex for faculty

Your academic CV and NIH biosketch

Make your CV in your school's format and your NIH biosketch from it, then download both as Word files.

RFA-DA-23-014: Avenir Award Program for Chemistry and Pharmacology of Substance Use Disorders (DP1- Clinical Trial Not Allowed) | ScienceDex | ConductScience